ESR1 and breast cancer: For example, loss of E-cadherin and ESR1 due to promoter hypermethylation have been reported in primary breast carcinoma cells[64] and doxorubicin-resistant breast cancer cells[53] and demethylation restored the expression levels of these genes[64].